ScinoPharm Taiwan Ltd Sustainability Reports
The company specializes in the research, development, and manufacture of cGMP-compliant active pharmaceutical ingredients (APIs) and provides contract development and manufacturing organization (CDMO) services.
Sector: Manufacturing
Country: Taiwan
Exchange: Taiwan Stock Exchange
FIGI: BBG001SQH4Q4
19 reports from 2013 to 2025
